FDA’s CBE Codification Could Help Defendants

January 17, 2008
This article examines amendments proposed by the FDA to its regulations governing a drug, biologic or medical device manufacturer’s ability to implement labeling changes in advance of agency review and approval in an effort to codify the agency’s longstanding position and practice regarding CBE supplement requirements.